Spirulina Guru markSpirulina.Guru

Science

Spirulina and Sphingosine 1-Phosphate Signalling: S1P Receptors, SphK1/2, and Cell Trafficking

S1P is a bioactive sphingolipid that controls lymphocyte trafficking, endothelial barrier integrity, and cell survival through five GPCRs. It opposes ceramide in the sphingolipid rheostat.

spirulina and sphingosine 1 phosphate

S1P Biosynthesis: SphK1/2 and the Sphingolipid Rheostat

Sphingosine 1-phosphate (S1P) is produced by phosphorylation of sphingosine by sphingosine kinase 1 (SphK1, cytosolic, translocates to plasma membrane upon activation) and SphK2 (nuclear/mitochondrial, inhibits HDAC1/2). Sphingosine is derived from ceramide by ceramidase (ASAH1/2). The sphingolipid rheostat balances pro-apoptotic ceramide (via nSMase2/cPLA2/acid SMase) against pro-survival S1P (via SphK1). S1P is degraded by S1P lyase (SGPL1, irreversible cleavage to phosphoethanolamine and hexadecenal) or dephosphorylated by S1P phosphatases (SGPP1/2). Intracellular S1P is exported by ABCC1 (MRP1) and spinster-2 (SPNS2) for paracrine/autocrine S1PR signalling.

S1P Receptors: GPCRs and Downstream Signalling

Five S1P receptors (S1PR1-5, formerly EDG family) mediate S1P effects: S1PR1 (Gi/Rac): lymphocyte egress from lymph nodes (suppressed by FTY720/ fingolimod, causing lymphopenia); endothelial junction stabilisation (adherens junction Rac/cortactin/E-cadherin). S1PR2 (G12/13/Rho): opposing S1PR1 in lymphocyte retention and vascular permeability increase. S1PR3 (Gi/Gq): cardiac rate (S1PR3 on SA node, bradycardia), endothelial responses. S1PR4 (Gi, lymphoid tissue): lymphocyte proliferation/cytokine. S1PR5 (Gi, NK cells/brain): NK cell egress from bone marrow. S1P plasma gradient (high in blood from erythrocyte/endothelial secretion, low in tissues/lymph nodes) drives lymphocyte circulation via S1PR1.

S1P and Endothelial Barrier Function

S1P-S1PR1 on endothelial cells activates Gi-PI3K-Akt-Rac1, promoting cortical actin polymerisation (via TIAM1/Wave complex), E-cadherin-beta-catenin junction assembly, and VE-cadherin (CDH5) stabilisation at adherens junctions. This opposes VEGF/thrombin-driven vascular leak (which activates RhoA-ROCK-MLC phosphorylation causing stress fibres and junction disruption). Sphingosine lyase inhibition elevates tissue S1P, and S1P delivery reduces vascular permeability in sepsis and ischaemia models. Spirulina's ceramide-suppression (via nSMase2 inhibition by PCB) elevates the ceramide-to-S1P ratio in favour of S1P, supporting endothelial barrier integrity.

SphK2 Nuclear S1P and HDAC Inhibition

Nuclear SphK2-generated S1P directly binds to and inhibits HDAC1 and HDAC2 (class I HDACs), preventing deacetylation of histones H3 and H4 at specific loci, particularly the promoters of survivin (BIRC5) and c-fos. This HDAC-inhibitory S1P mechanism promotes gene expression and cell survival in a histone-code-dependent manner. Nuclear SphK2 activity is regulated by PKCdelta (Ser351 phosphorylation) and by AMPK. Spirulina's AMPK activation and PKC modulation may influence nuclear SphK2 activity, though direct spirulina-SphK2 nuclear evidence is lacking.

S1P-Ceramide Balance in Inflammation and Apoptosis

The S1P/ceramide rheostat is a key determinant of cell fate: ceramide promotes apoptosis (PP2A/Akt dephosphorylation, BAX mitochondrial targeting, cathepsin D release), while S1P promotes survival (S1PR-Gi-PI3K-Akt, Bcl-2 family stabilisation). In inflamed tissues, TNF-alpha and LPS activate neutral SMase2 (SMPD3) to generate ceramide. Spirulina's PCB inhibits nSMase2 (reducing ceramide), and AMPK promotes ceramidase-SphK1 activity (increasing S1P synthesis). This shifts the rheostat toward survival and anti-inflammatory resolution.

S1P in Mast Cell and Lymphocyte Trafficking

Mast cells express SphK1 and S1PR1/2/3; FcepsilonRI crosslinking activates SphK1, generating S1P that amplifies degranulation in an autocrine manner. S1PR1 drives mast cell migration toward S1P gradients (toward blood vessels). Lymphocyte S1PR1 is required for T and B cell egress from thymus and lymph nodes; FTY720 (fingolimod) sequesters lymphocytes in lymph nodes via S1PR1 internalisation, achieving immunosuppression. Spirulina does not block lymphocyte egress (no S1PR1 internalisation effect reported), maintaining normal immune surveillance while attenuating mast cell SphK1-S1P autocrine loop via ceramide supply reduction.

Get the weekly digest

Curated science, recipes, and brand intel — once a week, no spam, unsubscribe in one click.

Members only · science

Create a free account to continue reading

This is one of 1,000+ mechanistic deep-dives available to members. Free to join — independent, evidence-honest, no paid placements.

  • Full access to all mechanistic pathway articles
  • Detailed brand reviews and dosing protocols
  • Clinical evidence updates and new posts first
  • Free — no credit card required

Spirulina Guru is independent — no paid placements, no MLM partnerships, no industry sponsorships.

Community

14,000+ spirulina enthusiasts — join the conversation

Spirulina Love is the longest-running organic spirulina group on Facebook, moderated by Yunus since 2007. Ask questions, share experiences, and discover which brands members actually trust.

Join Spirulina Love